Instrument Inactif

Communiqués Orthovita, Inc.

Actions

Equipement, fournitures et distribution médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

21/05/11	ORTHOVITA : Law Office of Brodsky & Smith, LLC Announces Investigation of Orthovita, Inc.	BU
17/05/11	ORTHOVITA : The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Orthovita, Inc. in Connection with the Sale of the Company to Stryker Corporation -- VITA	BU
17/05/11	ORTHOVITA : Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Orthovita, Inc. - VITA	BU
17/05/11	ORTHOVITA : Robbins Umeda LLP Is Investigating Orthovita, Inc. Acquisition for Shareholders	BU
16/05/11	ORTHOVITA : The Briscoe Law Firm Investigates Orthovita, Inc. for Shareholders Concerning Acquisition by Stryker Corporation	BU
16/05/11	ORTHOVITA : The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Orthovita, Inc. in Connection with the Sale of the Company to Stryker Corporation -- VITA	BU
16/05/11	ORTHOVITA : Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of Orthovita, Inc.	BU
16/05/11	ORTHOVITA : Orthovita, Inc. Agrees To Be Acquired by Stryker Corporation for $3.85 Per Share in Cash	BU
11/05/11	ORTHOVITA : Notes Noridian, a Medicare Contractor, Issues Future Local Coverage Decision Covering Vertebroplasty and Vertebral Augmentation	BU
10/05/11	ORTHOVITA : to Present at the Bank of America Merrill Lynch Health Care Conference	BU
04/05/11	ORTHOVITA : Reports 2011 First Quarter Financial Results	BU
19/04/11	ORTHOVITA : Schedules First Quarter 2011 Financial Results Conference Call	BU
13/04/11	ORTHOVITA : Launches the Aliquot Directional Bone Tamp	BU
11/04/11	ORTHOVITA : Announces Presentation of Clinical Results Evaluating Vitagel? Surgical Hemostat in Reducing Blood Loss During Primary Unilateral Total Knee Arthroplasty	BU
08/03/11	ORTHOVITA : Reports 2010 Fourth Quarter and Year-End Financial Results and Provides 2011 Financial Guidance	BU
16/02/11	ORTHOVITA : Launches Vitoss? Bioactive Foam-2X Bone Graft Substitute at AAOS (American Academy of Orthopedic Surgeons) Meeting	BU
14/02/11	ORTHOVITA : Schedules Conference Call for Fourth Quarter and Year-End 2010 Financial Results and 2011 Guidance	BU
10/02/11	ORTHOVITA : Receives FDA Clearance for Vitoss? Bimodal Bone Graft Substitute	BU
08/02/11	ORTHOVITA : to Present at the Canaccord Genuity Musculoskeletal Conference	BU
15/12/10	ORTHOVITA : to Present at the J.P. Morgan 29th Annual Healthcare Conference	BU
07/12/10	ORTHOVITA : Receives FDA Clearance for Vitoss? Bioactive Foam-2X Bone Graft Substitute	BU
17/11/10	ORTHOVITA : to Present at the Piper Jaffray 22nd Annual Health Care Conference	BU
04/11/10	ORTHOVITA : to Present at the Maxim Group 4th Annual Growth Conference	BU
02/11/10	ORTHOVITA : Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance	BU
01/11/10	ORTHOVITA : to Present at the Lazard Capital Markets 7th Annual Healthcare Conference	BU